Your SlideShare is downloading. ×
Contraceptives – pipeline review, h2 2012
Contraceptives – pipeline review, h2 2012
Contraceptives – pipeline review, h2 2012
Contraceptives – pipeline review, h2 2012
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Contraceptives – pipeline review, h2 2012

137

Published on

2012 Aarkstore.com | Contraceptives – Pipeline Review, H2 2012

2012 Aarkstore.com | Contraceptives – Pipeline Review, H2 2012

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
137
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Aarkstore.com announces, The Latest market research report is available inits vast collection:Contraceptives – Pipeline Review, H2 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Contraceptives - Pipeline Review, H2 2012, provides anoverview of the Contraceptives therapeutic pipeline. This report providesinformation on the therapeutic development for Contraceptives, complete withlatest updates, and special features on late-stage and discontinued projects. It alsoreviews key players involved in the therapeutic development for Contraceptives.Contraceptives - Pipeline Review, H2 2012 is built using data and informationsourced from Global Markets Direct’s proprietary databases, Company/Universitywebsites, SEC filings, investor presentations and featured press releases fromcompany/university sites and industry-specific third party sources, put together byGlobal Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Contraceptives.- A review of the Contraceptives products under development by companies anduniversities/research institutes based on information derived from company andindustry-specific sources.- Coverage of products based on various stages of development ranging from
  • 2. discovery till registration stages.Table of contents:List of Tables 6List of Figures 7Introduction 8Global Markets Direct Report Coverage 8Contraceptives Overview 9Therapeutics Development 10An Overview of Pipeline Products for Contraceptives 10Contraceptives Therapeutics under Development by Companies 12Late Stage Products 15Comparative Analysis 15Mid Clinical Stage Products 16Comparative Analysis 16Early Clinical Stage Products 17Comparative Analysis 17Pre-Clinical Stage Products 18Comparative Analysis 18Contraceptives Therapeutics – Products under Development by Companies 19Companies Involved in Contraceptives Therapeutics Development 21Antares Pharma, Inc. 21Watson Pharmaceuticals, Inc. 22Merck & Co., Inc. 23BioSante Pharmaceuticals, Inc. 24Teva Pharmaceutical Industries Limited 25Bayer AG 26Ligand Pharmaceuticals Incorporated 27HRA Pharma, SA 28Pantarhei Bioscience BV 29Hydra Biosciences, Inc. 30Agile Therapeutics, Inc. 31Adamis Pharmaceuticals Corporation 32CONRAD 33Contraceptives – Therapeutics Assessment 34
  • 3. Assessment by Monotherapy Products 34Assessment by Route of Administration 35Assessment by Molecule Type 37Drug Profiles 39MK-8175A - Drug Profile 39Product Description 39Mechanism of Action 39List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H22012&PubId=&pagenum=1Astrocytoma – Pipeline Review, H2 2012Autoimmune Disorders – Pipeline Review, H2 2012HIV / AIDS – Pipeline Review, H2 2012Contraceptives – Pipeline Review, H2 2012Metastatic Prostate Cancer – Pipeline Review, H2 2012Fungal Infections – Pipeline Review, H2 2012Mycobacterium Infections – Pipeline Review, H2 2012
  • 4. Brain Cancer – Pipeline Review, H2 2012Metastatic Colorectal Cancer – Pipeline Review, H2 2012Orthomyxoviridae Infections – Pipeline Review, H2 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com

×